1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Central America Pharmaceuticals and Healthcare Report Q4 2015

Central America Pharmaceuticals and Healthcare Report Q4 2015

  • August 2015
  • -
  • Business Monitor International
  • -
  • 59 pages

Includes 3 FREE quarterly updates

BMI View: Growing demand for pharmaceuticals, compounded by underdeveloped manufacturing capabilities will ensure commercial opportunities for foreign investors within Central America over the long term. Multinational drugmakers and medical suppliers will also continue to benefit from favourable tax incentives and growing medicine consumption driven by a booming burden of chronic disease. Sluggish economies and political instability will remain problematic, though pharmaceutical and health expenditure will continue to rise throughout the region.

Headline Expenditure Projections

- Pharmaceuticals: USD3.7bn in 2014 to USD3.9bn in 2015; +5.6%. Our forecast has been maintained since Q315.
- Healthcare: USD16.8bn in 2014 to USD17.8bn in 2015; +5.8%. Our forecast has been revised upwards since Q315 due to revised historical data.

Table Of Contents

Central America Pharmaceuticals and Healthcare Report Q4 2015
BMI Industry View 7
SWOT 9
SWOT 9
Industry Forecast 10
Pharmaceutical Market Forecast 10
Table: Central America Pharmaceutical Sales, Historic Data And Forecasts 12
Guatemala 12
Table: Guatemala Pharmaceutical Sales Forecasts 12
Costa Rica 13
Table: Costa Rica Pharmaceutical Sales Forecasts 13
El Salvador 13
Table: El Salvador Pharmaceutical Sales Forecasts 13
Honduras 14
Table: Honduras Pharmaceutical Sales Forecasts 14
Panama 14
Table: Panama Pharmaceutical Sales Forecasts 14
Nicaragua 15
Table: Nicaragua Pharmaceutical Sales Forecasts 15
Healthcare Market Forecast 16
Table: Central America Healthcare Expenditure Trends, Historical Data And Forecasts 18
Guatemala 18
Table: Guatemala Healthcare Expenditure Forecasts 18
Costa Rica 18
Table: Costa Rica Healthcare Expenditure Forecasts 19
El Salvador 19
Table: El Salvador Healthcare Expenditure Forecasts 19
Panama 19
Table: Panama Healthcare Expenditure Forecasts 20
Honduras 20
Table: Honduras Healthcare Expenditure Forecasts 20
Nicaragua 21
Table: Nicaragua Healthcare Expenditure Forecasts 21
Pharmaceutical Trade Forecast 22
Guatemala 24
Table: Guatemala Pharmaceutical Trade Data And Forecasts (USDmn) 24
Costa Rica 24
Table: Costa Rica Pharmaceutical Trade Data And Forecasts (USDmn) 25
El Salvador 25
Table: El Salvador Pharmaceutical Trade Data And Forecasts (USDmn) 25
Panama 25
Table: Panama Pharmaceutical Trade Data And Forecasts (USDmn) 26
Honduras 26
Table: Honduras Pharmaceutical Trade Data And Forecasts (USDmn) 26
Nicaragua 26
Table: Nicaragua Pharmaceutical Trade Data And Forecasts (USDmn) 27
Industry Risk Reward Indices 28
Americas Risk/Reward Index - Q4 2015 28
Central America Risk/Reward Index 33
Rewards 34
Risks 34
Industry Trends And Developments 35
Epidemiology 35
Healthcare Sector 36
Guatemala 37
Costa Rica 37
El Salvador 38
Panama 39
Honduras 40
Nicaragua 41
Clinical Trials 41
Regulatory Development 44
Intellectual Property Regime 44
Costa Rica 45
El Salvador 46
Honduras 46
Nicaragua 47
Guatemala 47
Competitive Landscape 48
Company Profile 49
Ancalmo Internacional 49
Donovan Werke 51
Glossary 53
Methodology 55
Pharmaceutical Expenditure Forecast Model 55
Healthcare Expenditure Forecast Model 55
Notes On Methodology 56
Risk/Reward Index Methodology 57
Index Overview 58
Table: Pharmaceutical Risk/Reward Index Indicators 58
Indicator Weightings 59

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.